A61P 35 - Antineoplastic agents

Patents for A61P 35 - Antineoplastic agents (221,099)
12/2004
12/29/2004	EP1263723A4 Ningalin b analogs employable for reversing multidrug resistance
12/29/2004	EP1233769A4 Novel compounds
12/29/2004	EP1226136B1 Tyrosine kinase inhibitors
12/29/2004	EP1216234B1 Mediators of hedgehog signaling pathways, compositions and uses related thereto
12/29/2004	EP1214345B1 Agents for treating human diseases, especially for treating tumors such as colonic cancers and melanomas or for regenerating tissue and promoting hair growth
12/29/2004	EP1206442A4 Substituted chiral allosteric hemoglobin modifiers
12/29/2004	EP1204646B1 1,4,5,6 -tetrahydropyrimidine derivative as a vitronectin inhibitor
12/29/2004	EP1196616B1 Replication-competent anti-cancer vectors
12/29/2004	EP1177178B1 Heterocyclically substituted benzimidazoles, the production and application thereof
12/29/2004	EP1146909A4 Method of treating cancer by restoration of pp32 function
12/29/2004	EP1135123B1 Use of isatin derivatives as ion channel activating agents
12/29/2004	EP1123274B1 Substituted phenyl derivatives, their preparation and use
12/29/2004	EP1119551B1 Naphthalenecarboxamides as tachykinin receptor antagonists
12/29/2004	EP1117643B1 New crystal modification n of torasemide
12/29/2004	EP1056729B1 N-[(substituted five-membered di- or triaza diunsaturated ring)carbonyl]guanidine derivatives for the treatment of ischemia
12/29/2004	EP1028757B1 Radioactive embolizing compositions
12/29/2004	EP1003745B1 Naphthyridinones for inhibiting protein tyrosine kinase and cell cycle kinase mediated cellular proliferation
12/29/2004	EP0935651B1 THERAPY FOR alpha-GALACTOSIDASE A DEFICIENCY
12/29/2004	EP0934303B1 Compounds useful for inhibition of farnesyl protein transferase
12/29/2004	EP0929545B1 Tricyclic inhibitors of farnesyl protein transferase
12/29/2004	EP0890361B1 HGF mutant and its use as an anticancer agent
12/29/2004	EP0725635B1 Phenylacetate and derivatives alone or in combination with other compounds against neoplastic conditions and other disorders
12/29/2004	EP0722342B1 REGULATION OF bcl-2 GENE EXPRESSION
12/29/2004	EP0653940B1 Glial mitogenic factors, their preparation and use
12/29/2004	CN1558950A Somatic cell derived embryonic stem cell and its differentiated cell
12/29/2004	CN1558914A Receptor, the use thereof, and mouse antibodies
12/29/2004	CN1558909A Supermolecular carboplatinum derivatives, their preparation method, and pharmaceutical composition containing them as active ingredient and applications of the composition
12/29/2004	CN1558905A Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation
12/29/2004	CN1558777A An antineoplastic dendritic polymer drug delivery system
12/29/2004	CN1558775A Antigen arrays presenting il-5, il-13 or eotaxin for treatment of allergic eosinophilic diseases
12/29/2004	CN1558761A Substituted benzimidazole compounds and their use for the treatment of cancer
12/29/2004	CN1558758A Novel pyrroles having hypolipidemic hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them and their use in medicine
12/29/2004	CN1557830A Process for preparing 20(R)-ginsenoside Rh2
12/29/2004	CN1557825A Platinum complex having anticancer activity
12/29/2004	CN1557823A L- or D-amino acid-platinum ligand ,preparation method and use thereof
12/29/2004	CN1557815A Isopentenyl xanthone compounds and their use in the preparation of antitumor medicines
12/29/2004	CN1557814A Homocamptoth-ecine compounds, their preparation process and use
12/29/2004	CN1557487A Immunogenicity composition for preventing and treating diseases and its preparation
12/29/2004	CN1557482A Immune function regulating and tumor resisting natural nutrient
12/29/2004	CN1557472A Antineoplastic natural nutrient
12/29/2004	CN1557452A Antineoplastic Chinese traditional medicine and its preparing process
12/29/2004	CN1557442A Liniment for skin and its preparation
12/29/2004	CN1557420A Method for extracting prostate cancer resisting active element from cole pollen
12/29/2004	CN1557392A Antitumor medicine
12/29/2004	CN1557387A Aromatic turmeric oil extracts and its preparing process and medicinal composition containing the same
12/29/2004	CN1557380A Anticancer oral administered Chinese medicinal preparation
12/29/2004	CN1557379A Anticanser medicine
12/29/2004	CN1557328A Application of 20(R)-ginsenoside Rh2 in pharmacy
12/29/2004	CN1557322A Use of diazocine analogue in preparation of antineoplastic and antifungal medicine
12/29/2004	CN1557313A Leukemia and myeloma treating plant extract and natural chemical monomer
12/29/2004	CN1557299A Injectio Natarii Norcantharidatis infusion and its preparation method
12/29/2004	CN1557298A Injectio Natarii Norcantharidatis freeze-drying powder injection and its preparation method
12/29/2004	CN1182154C Novel dolastatin derivatives, their preparation and use
12/29/2004	CN1182153C Novel dolastatin derivatives, their preparation and use
12/29/2004	CN1182143C Bis-(N,N'-bis-(2-haloethyl) amino) phosphoramidates as antitumor agents
12/29/2004	CN1182134C Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for treatment of pain
12/29/2004	CN1182123C Substituted bicyclic derivatives useful as anticancer agents
12/29/2004	CN1181890C Use of enterobacterium protein OmpA in the preparation of antigen presentation cells specified targeting medicine
12/29/2004	CN1181857C Anticancer capsule and preparing method thereof
12/29/2004	CN1181852C Medicine for treating bladder cancer
12/29/2004	CN1181851C Medicine for curing tumor
12/29/2004	CN1181841C Bladder cancer treating Chinese medicine
12/29/2004	CN1181839C Tumor treating antiphlogistic medicine liquid
12/29/2004	CN1181830C Yunnan Heiyao and its application in treating tumors
12/29/2004	CN1181829C 吉西他滨溶液制剂 Gemcitabine solution formulation
12/29/2004	CN1181825C Use of colchinol derivatives in preparation of vascular damaging agents drug
12/29/2004	CN1181822C Use of 2-amino-3,4-dihydro-quinazolines for producing medicament for treating or preventing diseases caused by ischaemia conditions
12/29/2004	CN1181819C Combination therapy using pentafluorobenzenesulfonamide
12/29/2004	CA2534748A1 Relaxin superfamily peptide analogues
12/29/2004	CA2529409A1 Compositions comprising zd6126 together with 5-fu, cpt-11 or 5-fu and cpt-11 having vascular damaging activity for treating e.g. colorectal cancer
12/29/2004	CA2529250A1 Chinazoline derivatives as aurora kinase inhibitors
12/29/2004	CA2529154A1 Novel compounds that modulate ppar.gamma. type receptors, and use thereof in cosmetic or pharmaceutical compositions
12/29/2004	CA2528771A1 Pyridino[1,2-a]pyrimidin-4-one compounds as anticancer agents
12/29/2004	CA2526647A1 Anti alpha - folate - receptor - tetramer antibodies
12/28/2004	US6835846 Aliphatic compounds, process for their preparation and their usage
12/28/2004	US6835837 Antiallergens; antiinflammatory agents; skin disorders; osteoporosis
12/28/2004	US6835826 Acid resistance, stability; telomerase inhibitor
12/28/2004	US6835752 Carboxylic acid derivatives, processes for the preparation thereof and pharmaceutical agents comprising the same as active ingredient
12/28/2004	US6835749 Sulfohydroxamic acids and sulfohydroxamates and their use as MEK inhibitors
12/28/2004	US6835744 3,3-substituted indoline derivatives
12/28/2004	US6835735 Anticancer, tyrosine kinase inhibitors
12/28/2004	US6835731 Chemokine receptor binding heterocyclic compounds
12/28/2004	US6835729 2-phenyl-1-[4(2-aminoethoxy)-benzyl]-indoles as estrogenic agents
12/28/2004	US6835727 Bone disorders; osteoporosis; rheumatic diseases
12/28/2004	US6835546 Drosophila G protein coupled receptors, nucleic acids, and methods related to the same
12/28/2004	US6835401 Method of treating diseases caused by over-production of free-radicals
12/28/2004	US6835372 Mixtures of di-(tri)peptides and drugs such as cyclosporin used as aerosols; drug delivery
12/28/2004	US6835370 Diagnosis and treatment of malignant neoplasms
12/28/2004	CA2441656C Electrolytic reduced water, anti-cancer drug, and producing method and apparatus thereof
12/28/2004	CA2226039C Pyridylfuran and pyridylthiophene compounds
12/28/2004	CA2128103C Formulation and use of carotenoids in treatment of cancer
12/25/2004	CA2472294A1 New derivatives of benzo[a]pyrano[3,2-h]acridin-7-one, a process for their preparation and pharmaceutical compounds containing them
12/23/2004	WO2004111215A1 Novel phosphorylated sequences of the phosphatase cdc25b, antibodies for said sequences and use thereof
12/23/2004	WO2004111090A2 Molecules for targeting and releasing therapeutic compounds, and the use thereof
12/23/2004	WO2004111075A2 Alternative reading frame polypeptides for treatment
12/23/2004	WO2004111058A1 Heteroryl-fused pyrimidinyl compounds as anticancer agents
12/23/2004	WO2004111052A1 Pyrrolopyrimidine derivatives as modulators of multi-drug resistance (mdr)
12/23/2004	WO2004111048A1 3-(guanidinocarbonyl)heterocycle derivatives, preparation process and intermediates of this process, their use as medicaments, and pharmaceutical compositions including them
12/23/2004	WO2004111037A1 Cyclic tertiary amine compound
12/23/2004	WO2004111024A1 Thiadiazoline derivative

1 ... 1340 1341 1342 1343 1344 1345 1346 1347 1348 1349 1350 1351 1352 1353 1354 1355 1356 1357 1358 1359 1360 ... 2211